HeartFlow NovoCure: Which Emerging Stock Is Best in 2026
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Evaluating the value of travel points against cash back can impact your rewards strategy. Discover which option offers the greatest benefits for your needs.
26,201 articlesHeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
A shift in how firms anchor themselves abroad is gaining momentum as U.S. and Chinese authorities scrutinize origin a...
XRP exchange-traded funds booked their first monthly net outflow after a $1.2 billion rally, signaling a shift in inv...
As AI systems evolve, a watchdog warns 'rogue deployment' risk at top labs. This deep dive explains what rogue deploy...
Markets reassess the Warsh era as fresh inflation figures arrive. Inflation data confirms kevin and pushes investors ...
Bitcoin cools after oil-driven volatility fades, shifting focus to liquidity, rate bets, and ETF flows as Brent trade...
A rebound appears to be taking shape in crushed software stocks as earnings from marquee players hint AI cannibalizat...
Bitcoin is under renewed pressure as on-chain signals show a large drawdown from the short-term holder cohort. About ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Long-term Treasuries moved higher again, signaling tougher borrowing costs ahead. The bond market just handed U.S. ta...
SMH investors are entering a pivotal July earnings season, with hyperscaler capex guidance set to determine the ETF's...
Markets moved sharply after kevin warsh showed that a hawkish stance remains intact for the Fed, lighting up yields a...